Disease and Therapy Review: Cervical Cancer

• Publication date: February 2012

The Cervical Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the cervical cancer market, as well as sales of leading drugs and therapies are provided. Disea...

The Cervical Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the cervical cancer market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.  

Pathology Industry in North America

I. OVERVIEW
General overview of the condition
Types of cervical cancer
Symptoms and signs
Risk factors
Staging
II. INCIDENCE, PREVALENCE AND MORTALITY
Incidence Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, UK, China, India, Indonesia, Japan, Philippines, Taiwan, Thailand, Egypt, South Africa, Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, Worldwide)
Prevalence Table (Canada, U.S., Mexico, France, Germany, Italy, Spain, UK, China, India, Japan, Worldwide)
Mortality Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, UK, China, India, Indonesia, Japan, Philippines, Taiwan, Thailand, Vietnam, Egypt, South Africa, Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, Worldwide)
Survival rates by stage
III. DIAGNOSIS
Screening
Diagnostic tools and procedure
IV. TREAMENT
Prevention
Emergency treatment
Treatment by stage
V. TREATMENT COSTS
Overview of costs for common treatments
VI. MARKET SIZE
Overall market size
Sales information for key pharmaceuticals
VII. COMMENTS
VIII. REFERENCES/RESOURCES